Medgenics, Inc.
                         ('Medgenics' or the 'Company')
                                        
                              Total Voting Rights

30 June 2008

Following  the  block listing interim review on 4 June 2008, and  in  accordance
with  the Financial Services Authority's Disclosure and Transparency Rules,  the
Company hereby announces that it has 106,698,096 common shares of US$0.0001 each
in  issue, each share carrying the right to one vote. The Company does not  hold
any common shares in Treasury.

The above figure of 106,698,096 common shares may be used by shareholders in the
Company as the denominator for the calculations by which they will determine  if
they are required to notify their interest in, or a change to their interest in,
the  share  capital  of  the  Company under the Financial  Services  Authority's
Disclosure and Transparency Rules.

For further information, contact:

Medgenics, Inc.               +972 4 958 8555
Dr. Andrew L. Pearlman

Blomfield Corporate Finance   +44 207 489 4500
James Pinner or
Alan MacKenzie

SVS Securities plc            +44 207 638 5600
Peter Manfield or
Ian Callaway

Citigate Dewe Rogerson        +44 207 638 9571
Jonathan Shillington or
Mark Swallow or
Chris Gardner
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Medgenics(Regs) Charts.
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Medgenics(Regs) Charts.